Equities

CRISM' Therapeutics Corp

CRTX:LSE

CRISM' Therapeutics Corp

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)9.50
  • Today's Change0.00 / 0.00%
  • Shares traded7.97k
  • 1 Year change--
  • Beta1.6416
Data delayed at least 20 minutes, as of Oct 04 2024 14:13 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2023, CRISM' Therapeutics Corp increased its cash reserves by 20.97%, or 611.34k. Cash Flow from Investing totalled 28.10m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 2.23m for operations while cash used for financing totalled 25.30m.
Cash flow per share-0.0007
Price/Cash flow per share--
Book value per share0.0634
Tangible book value per share0.0617
More ▼

Balance sheet in GBPView more

CRISM' Therapeutics Corp has a strong Balance Sheet and has consistently grown its cash reserves over the last four years to total 3.44m.
Current ratio6.56
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.